Surface Plasmon Resonance Assay for Identification of Small Molecules Capable of Inhibiting Aβ Aggregation.

ACS Applied Materials & Interfaces
Jeeyeon LeeChwee Teck Lim

Abstract

Toxic aggregates of amyloid-beta (Aβ) have importance in the pathology of Alzheimer's disease, and inhibition of aggregate formation is considered to be a promising strategy for drug development. Here, we report a simple and rapid surface plasmon resonance (SPR) assay method that can identify potential Aβ aggregation inhibitors. Our assay is based on the SPR shifting of the Aβ-gold nanoparticle (Aβ-GNP) aggregates by size under the influence of an Aβ aggregation inhibitor. This user-friendly assay features a short assay time with a low reagent consumption that can be easily adapted as a high-throughput screen. We demonstrated that an effective Aβ aggregation inhibitor induces the blue-shifted SPR peaks of the Aβ-GNP aggregates by hindering the formation of long fibrillar aggregates. Moreover, the blue shifting was correlated to the efficacy and concentrations of an Aβ aggregation inhibitor. Overall, our findings suggest that our simple SPR assay can be a powerful tool to screen small molecules targeting Aβ aggregation.

References

Feb 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·A LomakinD B Teplow
Aug 1, 2002·The Journal of Biological Chemistry·Youcef Fezoui, David B Teplow
Mar 3, 2004·Journal of Neuroscience Research·Kenjiro OnoMasahito Yamada
Apr 3, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jie LiAnthony L Fink
Dec 14, 2004·The Journal of Biological Chemistry·Fusheng YangGregory M Cole
Feb 19, 2005·The Journal of Biological Chemistry·Bakthisaran RamanYuji Goto
Sep 30, 2005·Journal of the American Chemical Society·Sandra Chimon, Yoshitaka Ishii
Dec 13, 2005·Proceedings of the National Academy of Sciences of the United States of America·Luis CruzH Eugene Stanley
Jan 13, 2006·Nano Letters·Marcelo J KoganVictor F Puntes
Feb 3, 2007·Proceedings of the National Academy of Sciences of the United States of America·Tommy CedervallSara Linse
May 9, 2007·Proceedings of the National Academy of Sciences of the United States of America·Sara LinseKenneth A Dawson
Apr 17, 2008·Neurochemical Research·L RossiG Rotilio
Aug 15, 2009·PLoS Computational Biology·Stefan AuerMichele Vendruscolo
Aug 29, 2009·Journal of the American Chemical Society·Isaac Ojea-Jiménez, Victor Puntes
Nov 3, 2009·Journal of the American Chemical Society·Sarmad S HindoMi Hee Lim
Mar 2, 2010·Nature Reviews. Drug Discovery·Adriano Aguzzi, Tracy O'Connor
Jun 22, 2011·Chemical Reviews·Morteza MahmoudiSophie Laurent
Nov 22, 2011·Nature Chemical Biology·Jan BieschkeErich E Wanker
Feb 3, 2012·Chemical Reviews·Krishnendu SahaVincent M Rotello
Jan 8, 2013·Archives of Medical Research·David OrmeñoJorge Parodi
Feb 14, 2013·Dalton Transactions : an International Journal of Inorganic Chemistry·Erika FerrariMonica Saladini
May 7, 2013·Annual Review of Biomedical Engineering·Gang BaoSheng Tong
Nov 14, 2013·Nano Letters·Yanina D AlvarezFernando D Stefani
Jul 16, 2014·Alzheimer's Research & Therapy·Jeffrey L CummingsKate Zhong
Aug 8, 2014·Chemical Society Reviews·Kevin J Barnham, Ashley I Bush
Feb 24, 2015·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Timothy M RyanColin L Masters
Feb 21, 2016·Journal of Molecular Graphics & Modelling·Myeongsang LeeSungsoo Na
Feb 24, 2016·Current Medicinal Chemistry·Solomon Habtemariam
Mar 24, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Xiaowei ZengSi-Shen Feng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.